Variable neuroendocrine-immune dysfunction in individuals with unfavorable outcome after severe traumatic brain injury

Brain, Behavior, and Immunity

Volumn 45, Issue , 2015, Pages 15-27

  Santarsieri, M ^a   Kumar, R G ^a   Kochanek, P M ^a,c   Berga, S ^d,e   Wagner, A K ^a,b,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

^e WAKE FOREST BAPTIST HEALTH   (United States)

Author keywords

Cell adhesion molecule; Cerebrospinal fluid; Cortisol; Cytokines; GOS; Hypothalamic pituitary axis; Inflammation; Rehabilomics; Trajectory analysis; Traumatic brain injury

Indexed keywords

FAS ANTIGEN; HYDROCORTISONE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; CITICOLINE; FAS LIGAND; FASLG PROTEIN, HUMAN; ICAM1 PROTEIN, HUMAN; IL10 PROTEIN, HUMAN; IL1B PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; INTERLEUKIN 1BETA; NOOTROPIC AGENT; TUMOR NECROSIS FACTOR;

ADRENAL INSUFFICIENCY; ADULT; AGE; AGED; ARTICLE; CEREBROSPINAL FLUID LEVEL; COHORT ANALYSIS; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIFFUSE AXONAL INJURY; EMERGENCY CARE; FEMALE; GLASGOW OUTCOME SCALE; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOPATHOLOGY; INJURY SEVERITY; MAJOR CLINICAL STUDY; MALE; MORTALITY; NERVOUS SYSTEM INFLAMMATION; NEUROENDOCRINE DISEASE; NEUROENDOCRINE SYSTEM; NEUROIMAGING; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SIGNAL TRANSDUCTION; SUBARACHNOID HEMORRHAGE; SUBDURAL HEMATOMA; TRAUMATIC BRAIN INJURY; ADOLESCENT; BRAIN INJURIES; CASE CONTROL STUDY; CEREBROSPINAL FLUID; DOUBLE BLIND PROCEDURE; IMMUNOLOGY; INDUCED HYPOTHERMIA; INFLAMMATION; INJURY SCALE; MIDDLE AGED; PROCEDURES; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BRAIN INJURIES; CASE-CONTROL STUDIES; COHORT STUDIES; CYTIDINE DIPHOSPHATE CHOLINE; DOUBLE-BLIND METHOD; FAS LIGAND PROTEIN; FEMALE; GLASGOW OUTCOME SCALE; HUMANS; HYDROCORTISONE; HYPOTHERMIA, INDUCED; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-10; INTERLEUKIN-1BETA; INTERLEUKIN-6; MALE; MIDDLE AGED; NOOTROPIC AGENTS; PROGNOSIS; PROSPECTIVE STUDIES; TRAUMA SEVERITY INDICES; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84924207794     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2014.09.003     Document Type: Article

References (122)

1. Alderson P., Roberts I. Corticosteroids in acute traumatic brain injury: a systemic review of randomized controlled trials. BMJ 1997, 314(7098):1855-1859.
2. Amor S., Puentes F., Baker D., van der Valk P. Inflammation in neurodegenerative diseases. Immunology 2009, 129:154-169.
3. Andaluz-Ojeda D., Bobillo F., Iglesias V., Almansa R., Rico L., Gandia F., Resino S., Tamayo E., de Lejarazu R.O., Bermejo-Martin J.F. A combined score of pro- and anti-inflammatory interleukins improves mortality prediction in severe sepsis. Cytokine 2012, 57(3):332-336.
4. Annane D., Sebille V., Charpentier C., Bollaert P.E., Francois B., Korach J.M., Capellier G., Cohen Y., Azoulay E., Troche G., Chaumet-Riffaud P., Bellissant E. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality inpatients with septic shock. JAMA 2002, 288(7):862-871.
5. Ansar Ahmed S., Penhale W.J., Talal N. Sex hormones, immune responses, and autoimmune diseases. Mechanisms of sex hormone action. Am. J. Pathol. 1985, 121(3):531-551.
6. Bal-Price A., Brown G.C. Inflammatory neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal respiration, causing glutamate release and excitotoxicity. J. Neurosci. 2001, 21:6480-6491.
7. Banks W.A. Blood-brain barrier transport of cytokines: a mechanism for neuropathology. Curr. Pharm. Des. 2005, 11(8):973-984.
8. Baron R.M., Kenny D.A. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J. Pers. Soc. Psychol. 1986, 51(6):1173-1182.
9. Becher B., Prat A., Antel J.P. Brain-immune connection: immuno-regulatory properties of CNS resident cells. Glia 2000, 29(4):293-304.
10. Bell M.J., Kochanek P.M., Doughty L.A., Carcillo J.A., Adelson P.D., Clark R.S., Wisniewski S.R., Whalen M.J., DeKosky S.T. Interleukin-6 and interleukin-10 in cerebrospinal fluid after severe traumatic brain injury in children. J. Neurotrauma 1997, 14(7):451-457.
11. Besedovsky H.O., del Rey A. The cytokine-HPA axis feed-back circuit. Z. Rheumatol. 2000, 59(Suppl. 2: II):26-30.
12. Besedovsky H.O., del Rey A. Central and peripheral cytokines mediate immune-brain connectivity. Neurochem. Res. 2011, 36(1):1-6.
13. Besedovsky H.O., del Rey A., Klusman I., Furukawa H., Monge Arditi G., Kabiersch A. Cytokines as modulators of the hypothalamus-pituitary-adrenal axis. J. Steroid Biochem. Mol. Biol. 1991, 40(4-6):613-618.
14. Bird M.D., Karavitis J., Kovacs E.J. Sex differences and estrogen modulation of the cellular immune response after injury. Cell Immunol. 2008, 252(1-2):57-67.
15. Boelen A., Platvoet-Ter Schiphorst M.C., Wiersinga W.M. Soluble cytokine receptors and the low 3,5,3'-triiodothyronine syndrome in patients with nonthyroidal disease. J. Clin. Endocrinol. Metab. 1995, 80(3):971-976.
16. Brain Trauma Foundation Guidelines for the management of severe traumatic brain injury. J. Neurotrauma 2007, 24(Suppl. 1):S1-S106. American Association of Neurological Surgeons, and Congress of Neurological Surgeons.
17. Brand R.E., Nolen B.M., Zeh H.J., Allen P.J., Eloubeidi M.A., Goldberg M., Elton E., Arnoletti J.P., Christein J.D., Vickers S.M., Langmead C.J., Landsittel D.P., Whitcomb D.C., Grizzle W.E., Lokshin A.E. Serum biomarker panels for the detection of pancreatic cancer. Clin. Cancer Res. 2011, 17(4):805-816.
18. Carroll B.J., Curtis G.C., Mendels J. Neuroendocrine regulation in depression. I. Limbic system-adrenocortical dysfunction. Arch. Gen. Psychiatry 1976, 33(9):1039-1044.
19. Chantong B., Kratschmar D.V., Nashev L.G., Balazs Z., Odermatt A. Mineralocorticoid and glucocorticoid receptors differentially regulate NF-kappaB activity and pro-inflammatory cytokine production in murine BV-2 microglial cells. J. Neuroinflammation 2012, 9:260.
20. Chrousos G.P. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N. Engl. J. Med. 1995, 332:1351-1363.
21. Cohan P., Wang C., McArthur D.L., Cook S.W., Dusick J.R., Armin B., Swerdloff R., Vespa P., Muizelaar J.P., Cryer H.G., Christenson P.D., Kelly D.F. Acute secondary adrenal insufficiency after traumatic brain injury: a prospective study. Crit. Care Med. 2005, 33(10):2358-2366.
22. Cohen S., Janicki-Deverts D., Doyle W.J., Miller G.E., Frank E., Rabin B.S., Turner R.B. Chronic stress, glucocorticoid receptor resistance, inflammation and disease risk. Proc. Natl. Acad. Sci. U.S.A. 2012, 109(16):5995-5999.
23. Correale J., Villa A. The neuroprotective role of inflammation in nervous system injuries. J. Neurol. 2004, 251(11):1304-1316.
24. Correia L.C., Andrade B.B., Borges V.M., Clarencio J., Bittencourt A.P., Freitas R., Souza A.C., Almeida M.C., Leal J., Esteves J.P., Barral-Netto M. Prognostic value of cytokines and chemokines in addition to the GRACE Score in non-ST-elevation acute coronary syndromes. Clin. Chim. Acta 2010, 411(7-8):540-545.
25. Cousar J.L., Conley Y.P., Willyerd F.A., Sarnaik A.A., Puccio A.M., Empey P.E., Kochanek P.M., Bell M.J., Okonkwo D.O., Clark R.S. Influence of ATP-binding cassette polymorphisms on neurological outcome after traumatic brain injury. Neurocrit. Care 2013, 19(2):192-198.
26. Dardiotis, E., Karanikas, V., Paterakis, K., Fountas, K., Hadjigeorgiou, G.M., 2012. traumatic brain injury and inflammation: emerging role of innate and adaptive immunity, brain injury - pathogenesis, monitoring, recovery and management. In: Prof. Amit Agrawal (Ed.), ISBN: 978-953-51-0265-6, InTech, doi: Available from: http://www.intechopen.com/books/brain-injury-pathogenesis-monitoring-recovery-and-management/traumatic-brain-injury-and-inflammation-emerging-role-of-innate-and-adaptive-immunity.
27. Dash P.K., Zhao J., Hergenroeder G., Moore A.N. Biomarkers for the diagnosis, prognosis, and evaluation of treatment efficacy for traumatic brain injury. Neurotherapeutics 2010, 7(1):100-114.
28. Desborough J.P. The stress response to trauma and surgery. Br. J. Anaesth. 2000, 85(1):109-117.
29. Dinkel K., MacPherson A., Sapolsky R.M. Novel glucocorticoid effects on acute inflammation in the CNS. J. Neurochem. 2003, 84(4):705-716.
30. Dinkel K., Ogle W.O., Sapolsky R.M. Glucocorticoids and central nervous system inflammation. J. NeuroVirol. 2002, 8:513-528.
31. Dooms H. Interleukin-7: fuel for the autoimmune attack. J. Autoimmun. 2013, 45:40-48.
32. Efron B. Better bootstrap confidence intervals. J. Am. Stat. Assoc. 1987, 82(397):171-185.
33. Elenkov I.J. Glucocorticoids and the Th1/Th2 balance. Ann. N. Y. Acad. Sci. 2004, 1024:138-146.
34. Elenkov I.J. Neurohormonal-cytokine interactions: implications for inflammation, common human diseases and well-being. Neurochem. Int. 2008, 52(1-2):40-51.
35. Faden A.I. Neuroprotection and traumatic brain injury: the search continues. Arch. Neurol. 2001, 58(10):1553-1555.
36. Gehrmann J., Matsumoto Y., Kreutzberg G.W. Microglia: intrinsic immuneffector cell of the brain. Brain Res. Rev. 1995, 20(3):269-287.
37. Gentleman S.M., Leclercq P.D., Moyes L., Graham D.I., Smith C., Griffin W.S.T., Nicoll J.A.R. Long-term intracerebral inflammatory response after traumatic brain injury. Forensic Sci. Int. 2004, 146:97-104.
38. Grund B., Sabin C. Analysis of biomarker data: logs, odds ratios and ROC curves. Curr. Opin. HIV AIDS 2010, 5(6):473-479.
39. Helmy A., Carpenter K.L., Menon D.K., Pickard J.D., Hutchinson P.J. The cytokine response to human traumatic brain injury: temporal profile and evidence for cerebral parenchymal production. J. Cereb. Blood Flow Metab. 2011, 31(2):658-670.
40. Hickey W.F. Leukocyte traffic in the central nervous system: the participants and their roles. Semin. Immunol. 1999, 11(2):125-137.
41. Hildreth A.N., Mejia V.A., Maxwell R.A., Smith P.W., Dart B.W., Barker D.E. Adrenal suppression following a single dose of etomidate for rapid sequence induction: a prospective randomized study. J. Trauma 2008, 65:573-579.
42. Holub M., Beran O., Dzupova O., Hnykova J., Lacinova Z., Prihodova J., Prochazka B., Helcl M. Cortisol levels in cerebrospinal fluid correlate with severity and bacterial origin of meningitis. Crit. Care 2007, 11:R41.
43. Hurley S.D., Olschowka J.A., O'Banion M.K. Cyclooxygenase inhibition as a strategy to ameliorate brain injury. Exp. Brain Res. 2002, 19(1):1-15.
44. Jabbi M., Korf J., Kema I.P., Hartman C., van der Pompe G., Minderaa R.B., Ormel J., den Boer J.A. Convergent genetic modulation of the endocrine stress response involves polymorphic variations of 5-HTT, COMT and MAOA. Mol. Psychiatry 2007, 12(5):483-490.
45. Jain K.K. Neuroprotection in traumatic brain injury. Drug Discov. Today 2008, 13(23-24):1082-1089.
46. Jennett B., Bond M. Assessment of outcome after severe brain damage. Lancet 1975, 1(7905):480-484.
47. Johnson V.E., Stewart J.E., Begbie F.D., Trojanowski J.Q., Smith D.H., Stewart W. Inflammation and white matter degeneration persist for years after a single traumatic brain injury. Brain 2013, 136(Pt. 1):28-42.
48. Jones B.L., Nagin D., Roeder K. A SAS procedure based on mixture models for estimating developmental trajectories. Soc. Meth. Res. 2001, 29:374-393.
49. Jozefowski S., Bobek M., Marcinkiewicz J. Exogenous but not endogenous prostanoids regulate cytokine secretion from murine bone marrow dendritic cells: EP2, DP, and IP but not EP1, EP3, and FP prostanoid receptors are involved. Int. Immunopharmacol. 2003, 3(6):865-878.
50. Juengst S.B., Kumar R.G., Failla M.D., Goyal A., Wagner A.K. Acute inflammatory biomarker profiles predict depression risk following moderate to severe traumatic brain injury. J. Head Trauma Rehabil. 2014, (Epub ahead of print).
51. Karssen A.M., Meijer O.C., van der Sandt I.C., Lucassen P.J., de Lange E.C., de Boer A.G., de Kloet E.R. Multidrug resistance P-glycoprotein hampers the access of cortisol but not of corticosterone to mouse and human brain. Endocrinology 2001, 142:2686-2694.
52. Kirchhoff C., Buhmann S., Bogner V., Stegmaier J., Leidel B.A., Braunstein V., Mutschler W., Biberthaler P. Cerebrospinal IL-10 concentration is elevated in non-survivors as compared to survivors after severe traumatic brain injury. Eur. J. Med. Res. 2008, 13(10):464-468.
53. Kirschbaum C., Prussner J.C., Stone A.A., Federenko I., Gaab J., Lintz D., Schommer N., Hellhammer D.H. Persistent high cortisol responses to repeated psychological stress in a subpopulation of healthy men. Psychosom. Med. 1995, 57(5):468-474.
54. Kochanek P.M., Berger R.P., Bayir H., Wagner A.K., Jenkins L.W., Clark R.S. Biomarkers of primary and evolving damage in traumatic and ischemic brain injury: diagnosis, prognosis, probing mechanisms, and therapeutic decision making. Curr. Opin. Crit. Care 2008, 14(2):135-141.
55. Kossmann T., Hans V.H., Imhof H.G., Stocker R., Grob P., Trentz O., Morganti-Kossmann C. Intrathecal and serum interleukin-6 and the acute-phase response in patients with severe traumatic brain injuries. Shock 1995, 4(5):311-317.
56. Kumar R., Bracken M.B., Clark A.N., Nick T.G., Melguizo M.S., Sander A.M. Relationship of preinjury depressive symptoms to outcomes 3 mos after complicated and uncomplicated mild traumatic brain injury. Am. J. Phys. Med. Rehabil. 2014, 93(8):687-702.
57. Kumar R.G., Boles J.A., Wagner A.K. Chronic inflammation after severe traumatic brain injury: characterization and associations with outcome at 6 and 12months postinjury. J. Head Trauma Rehabil. 2014, (Epub ahead of print).
58. Lenzlinger P.M., Morganti-Kossmann M.C., Laurer H.L., McIntosh T.K. The duality of the inflammatory response to traumatic brain injury. Mol. Neurobiol. 2001, 24(1-3):169-181.
59. Llompart-Pou J.I., Abadal J.M., Homar J., Ibanez J. Effect of barbiturate coma on adrenal response in patients with traumatic brain injury. J. Endocrinol. Invest. 2007, 30:393-398.
60. Loscher W., Potschka H. Blood-brain barrier active efflux transporters: ATP-binding cassette gene family. NeuroRx 2005, 2:86-98.
61. Lowenstein D.H. Traumatic brain injury: a glimpse of order among the chaos?. Ann. Neurol. 2009, 66:A7-A8.
62. MacKinnon D.P., Lockwood C.M., Williams J. Confidence limits for the indirect effect: distribution of the product and resampling methods. Multivar. Behav. Res. 2004, 39(1):99-128.
63. MacPherson A., Dinkel K., Sapolsky R. Glucocorticoids worsen excitotoxin-induced expression of pro-inflammatory cytokines in hippocampal cultures. Exp. Neurol. 2005, 194(2):376-383.
64. Mahon P.B., Zandi P.P., Potash J.B., Nestadt G., Wand G.S. Genetic association of FKBP5 and CRHR1 with cortisol response to acute psychosocial stress in health adults. Psychopharmacology (Berl) 2013, 227(2):231-241.
65. Maier S.F. Bi-directional immune-brain communication: implications for understanding stress, pain, and cognition. Brain Behav. Immun. 2002, 17(2):69-85.
66. Maier S.F., Goehler L.E., Fleshner M., Watkins L.R. The role of the vagus nerve in cytokine-to-brain communication. Ann. N. Y. Acad. Sci. 1998, 840:289-300.
67. Marik P.E., Zaloga G.P. Adrenal insufficiency in the critically ill: a new look at an old problem. Chest 2002, 122(5):1784-1796.
68. Mastorakos G., Chrousos G.P., Weber J.S. Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans. J. Clin. Endocrinol. Metab. 1993, 77(6):1690-1694.
69. McCauley S.R., Boake C., Levin H.S., Contant C.F., Song J.X. Postconcussional disorder following mild to moderate traumatic brain injury: anxiety, depression, and social support as risk factors and comorbidities. J. Clin. Exp. Neuropsychol. 2001, 23(6):792-808.
70. McClain C., Cohen D., Phillips R., Ott L., Young B. Increased plasma and ventricular fluid interleukin-6 levels in patients with head injury. J. Lab. Clin. Med. 1991, 118(3):225-231.
71. Meisel C., Schwab J.M., Prass K., Meisel A., Dirnagl U. Central nervous system injury-induced immune deficiency syndrome. Nat. Rev. Neurosci. 2005, 6(10):775-786.
72. Morganti-Kossmann M.C., Rancan M., Stahel P.F., Kossmann T. Inflammatory response in acute traumatic brain injury: a double-edged sword. Curr. Opin. Crit. Care 2002, 8(2):101-105.
73. Morganti-Kossmann M.C., Satgunaseelan L., Bye N., Kossman T. Modulation of immune response by head injury. Injury 2007, 38(12):1392-1400.
74. Munck A., Naray-Fejes-Toth A. Glucocorticoids and stress: permissive and suppressive actions. Ann. N. Y. Acad. Sci. 1994, 746:115-130.
75. Munck A., Guyre P.M., Holbrook N.J. Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr. Rev. 1984, 5(1):25-44.
76. Nagin D.S. Group-Based Modeling of Development 2005, Harvard University Press, Cambridge.
77. Neumann H., Kotter M.R., Franklin R.J.M. Debris clearance by microglia: an essential link between degeneration and regeneration. Brain 2009, 132(2):288-295.
78. Niyonkuru C., Wagner A.K., Ozawa H., Amin K., Goyal A., Fabio A. Group-based trajectory analysis applications for prognostic biomarker model development in severe TBI: a practical example. J. Neurotrauma 2013, 30(11):938-945.
79. Pace T.W., Hu F., Miller A.H. Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression. Brain Behav. Immun. 2007, 21(1):9-19.
80. Parkhurst C.N., Yang G., Ninan I., Savas J.N., Yates J.R., Lafaille J.J., Hempstead B.L., Littman D.R., Gan W.B. Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor. Cell 2013, 155(7):1596-1609.
81. Pearson A., de Vries A., Middleton S.D., Gillies F., White T.O., Armstrong I.R., Andrew R., Seckl J.R., MacLullich A.M. Cerebrospinal fluid cortisol levels are higher in patients with delirium versus controls. BMC Res. Notes 2010, 8:3-33.
82. Phelps C., Korneva E. NeuroImmune biology. Cytokines and the Brain 2008, vol. 6. Elsevier, Oxford.
83. Rahman A., Fazal F. Hug tightly and say goodbye: role of endothelial ICAM-1 in leukocyte transmigration. Antioxid. Redox Signal. 2009, 11(4):823-839.
84. Ramlackhansingh A.F., Brooks D.J., Greenwood R.J., Bose S.K., Turkheimer F.E., Kinnunen K.M., Gentleman S., Heckemann R.A., Gunanayagam K., Gelosa G., Sharp D.J. Inflammation after trauma: microglial activation and traumatic brain injury. Ann. Neurol. 2011, 70:374-383.
85. Ransohoff R.M., Kivisakk P., Kidd G. Three or more routes for leukocyte migration into the central nervous system. Nat. Rev. Immunol. 2003, 3(7):560-581.
86. Reichlin S. Neuroendocrine-immune interactions. N. Engl. J. Med. 1993, 329(17):1246-1253.
87. Reincke M., Allolio B., Wurth G., Winkelmann W. The hypothalamic-pituitary-adrenal axis in critical illness: response to dexamethasone and corticotropin-releasing hormone. J. Clin. Endocrinol. Metab. 1993, 77(1):151-156.
88. Reul J.M.H.M., De Kloet E.R. Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology 1985, 117(6):2505-2511.
89. Rivest R. Regulation of innate immune responses in the brain. Nat. Rev. Immunol. 2009, 9(6):429-439.
90. Roberts I., Yates D., Sandercock P., Farrell B., Wasserberg J., Lomas G., Cottingham R., Svoboda P., Brayley N., Mazairac G., Laloë V., Muñoz-Sánchez A., Arango M., Hartzenberg B., Khamis H., Yutthakasemsunt S., Komolafe E., Olldashi F., Yadav Y., Murillo-Cabezas F., Shakur H., Edwards P. Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial. Lancet 2004, 364(9442):1321-1328. and CRASH trial collaborators.
91. Roubenoff R., Harris T.B., Abad L.W., Wilson P.W., Dallal G.E., Dinarello C.A. Monocyte cytokine production in an elderly population: effect of age and inflammation. J. Gerontol. A Biol. Sci. Med. Sci. 1998, 53(1):M20-M26.
92. Ruff R.M., Camenzuli L., Meuller J. Miserable minority: emotional risk factors that influence the outcome of mild traumatic brain injury. Brain Inj. 1996, 10(8):551-565.
93. Santarsieri M., Niyonkuru C., McCullough E.H., Dobos J.A., Dixon C.E., Berga S.L., Wagner A.K. Cerebrospinal fluid cortisol and progesterone profiles and outcomes prognostication after severe traumatic brain injury. J. Neurotrauma 2014, (Epub ahead of print).
94. Sapolsky R.M. Stress, the Aging Brain, and the Mechanisms of Neuron Death 1992, The MIT Press, Cambridge.
95. Sapolsky R.M., Rivier C., Yamamoto G., Plotsky P., Vale W. Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science 1987, 238:522-524.
96. Sapolsky R.M., Romero M.L., Munck A.U. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr. Rev. 2000, 21(1):55-89.
97. Schinkel A.H. P-glycoprotein, a gatekeeper in the blood-brain barrier. Adv. Drug Deliv. Rev. 1999, 36(2-3):179-194.
98. Schwartz M., Shechter R. Systemic inflammatory cells fight off neurodegenerative disease. Nat. Rev. Neurol. 2010, 6:405-410.
99. Silverman M.N., Sternberg E.M. Glucocorticoid regulation of inflammation and its functional correlates: from HPA axis to glucocorticoid receptor dysfunction. Ann. N. Y. Acad. Sci. 2012, 1261:55-63.
100. Sorrells S.F., Sapolsky R.M. An inflammatory review of glucocorticoid actions in the CNS. Brain Behav. Immun. 2007, 21(3):259-272.
101. Sorrells S.F., Caso J.R., Munhoz C.D., Sapolsky R.M. The stressed CNS: when glucocorticoids aggravate inflammation. Neuron 2009, 64:33-39.
102. Stamatovic S.M., Keep R.F., Andjelkovic A.V. Brain endothelial cell-cell junctions: how to "open" the blood brain barrier. Curr. Neuropharmacol. 2008, 6(3):179-192.
103. Sternberg E.M., Hill J.M., Chrousos G.P., Kamilaris T., Listwak S.J., Gold P.W., Wilder R.L. Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats. Proc. Natl. Acad. Sci. 1989, 86(7):2374-2378.
104. Stoffel-Wagner B. Neurosteroid biosynthesis in the human brain and its clinical implications. Ann. N. Y. Acad. Sci. 2003, 1007:64-78.
105. Teasdale G.M., Comment on Bullock R., Lyeth B.G., Muizelaar J.P. Current status of neuroprotection trials for traumatic brain injury: lessons from animal models and clinical studies. Neurosurgery 1999, 45:207-220.
106. Tolias C.M., Bullock M.R. Critical appraisal of neuroprotection trials in head injury: what have we learned?. NeuroRx 2004, 1(1):71-79.
107. Traskman L., Tybring G., Asberg M., Bertilsson L., Lantto O., Schalling D. Cortisol in the CSF of depressed and suicidal patients. Arch. Gen. Psychiatry 1980, 37(7):761-767.
108. Turnbull A.V., Rivier C. Regulation of the HPA axis by cytokines. Brain Behav. Immun. 1995, 9(4):253-275.
109. Turnbull A.V., Rivier C.L. Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action. Physiol. Rev. 1999, 79(1):1-71.
110. Van den Berghe G., de Zegher F., Bouillon R. Clinical review 95: acute and prolonged critical illness as different neuroendocrine paradigms. J. Clin. Endocrinol. Metab. 1998, 83:1827-1834.
111. Wagner A.K., Zitelli K. A rehabilomics focused perspective on molecular mechanisms underlying neurological injury, complications, and recovery after severe TBI. Pathophysiology 2013, 20:39-48.
112. Wagner A.K., McCullough E.H., Niyonkuru C., Ozawa H., Loucks T.L., Dobos J.A., Brett C.A., Santarsieri M., Dixon C.E., Berga S.L., Fabio A. Acute serum hormone levels: characterization and prognosis after severe traumatic brain injury. J. Neurotrauma 2011, 28(6):871-888.
113. Wakelkamp I.M., Bakker O., Baldeschi L., Wiersinga W.M., Prummel M.F. TSH-R expression and cytokine profile in orbital tissue of active vs. inactive Graves' ophthalmopathy patients. Clin. Endocrinol. 2003, 58(3):280-287.
114. Wang X.S., Li B.Z., Hu L.F., Wen P.F., Zhang M., Pan H.F., Ye D.Q. Perspectives of the relationship between IL-7 and autoimmune diseases. Clin. Rheumatol. 2013, 32(12):1703-1709.
115. Wiegers G.J., Reul J.M. Induction of cytokine receptors by glucocorticoids: functional and pathological significance. Trends Pharmacol. Sci. 1998, 19(8):317-321.
116. Wiegers G.J., Labeur M.S., Stec I.E., Klinkert W.E., Holsboer F., Reul J.M. Glucocorticoids accelerate anti-T cell receptor-induced T cell growth. J. Immunol. 1995, 155(4):1893-1902.
117. Woodcock T., Morganti-Kossman M.C. The role of markers of inflammation in traumatic brain injury. Front. Neurol. 2013, 4:18.
118. Yeager M.P., Guyre P.M., Munck A.U. Glucocorticoid regulation of the inflammatory response to injury. Acta Anaesthesiol. Scand. 2004, 48(7):799-813.
119. Yeager M.P., Pioli P.A., Guyre P.M. Cortisol exerts bi-phasic regulation of inflammation in humans. Dose Response 2011, 9(3):332-347.
120. Yu L., Romero D.G., Gomez-Sanchez C.E., Gomez-Sanchez E.P. Steroidogenic enzyme gene expression in the human brain. Mol. Cell. Endocrinol. 2002, 190:9-17.
121. Yu S., Kim H.Y., Chang Y.J., DeKruyff R.H., Umetsu D.T. Innate lymphoid cells and asthma. J. Allergy Clin. Immunol. 2014, 133(4):943-950.
122. Zafonte R., Friedewald W.T., Lee S.M., Levin B., Diaz-Arrastia R., Ansel B., Eisenberg H., Timmons S.D., Temkin N., Novack T., Ricker J., Merchant R., Jallo J. The citicoline brain injury treatment (COBRIT) trial: design and methods. J. Neurotrauma 2009, 26(12):2207-2216.